Secure Your Counsel Before the Deadline
As an investor in Capricor Therapeutics, Inc., it's crucial that you stay informed about your rights and potential actions you can take. The Rosen Law Firm, a well-respected global investor rights law firm, is currently reminding purchasers of securities between specific dates of the significant upcoming deadlines surrounding a class action lawsuit.
Important Class Action Timeline
If you acquired Capricor Therapeutics, Inc. (NASDAQ: CAPR) securities during the specified class period, which runs from October 9 to July 10, don’t overlook the September 15 deadline for leading plaintiff motions. Missing this date could prevent you from taking a leadership role in the litigation process.
What’s at Stake?
Purchasing securities during the class period might entitle you to compensation through a contingency fee arrangement. This means you won’t have to cover any legal fees out-of-pocket while pursuing a possible recovery from the case. It’s an opportunity that could lead to significant financial relief if the class action is successful.
Next Steps for Investors
To join the Capricor class action and protect your investments, it's advisable to seek counsel as soon as possible. By contacting the Rosen Law Firm directly, you can express your interest in becoming part of the class action. Their attorneys have a proven record of success in similar cases, enhancing the chances of a favorable outcome for investors.
Insights on Rosen Law Firm's Reputation
Choosing the right legal representation can significantly influence the outcome of your claims. Rosen Law Firm has successfully led securities class actions for investors around the globe. This firm has achieved notable settlements and has been recognized as a top law firm in this field. They have recovered millions for their clients and continue to advocate fiercely for investor rights.
Details of the Allegations
The allegations in the class action involve misleading statements made by the defendants regarding Capricor’s lead drug candidate, deramiocel. Claims around its development and safety have raised concerns about whether investors were accurately informed during the class period. Given the gravity of the situation, the need for a qualified attorney to represent your interests has never been greater.
Get in Touch for More Information
For further assistance, you can reach out directly to Phillip Kim, Esq. at the Rosen Law Firm by phone or through their official communication channels. Take proactive steps to ensure you are represented and that your rights as an investor are upheld.
Frequently Asked Questions
What is the class action against Capricor Therapeutics about?
The class action focuses on misrepresentation concerning Capricor’s lead drug candidate, potentially affecting investors' financial decisions.
Who can join this class action lawsuit?
Investors who purchased Capricor securities during the designated period are eligible to join the class action.
What is the lead plaintiff deadline?
The deadline for filing to become a lead plaintiff in the class action is September 15, 2025.
How does the contingency fee arrangement work?
Under a contingency fee structure, you do not pay upfront legal costs; rather, your attorney is compensated from any settlements or awards.
What should I do if I haven't yet joined the class action?
Contact the Rosen Law Firm immediately to discuss your options for joining the class action and securing your rights.
